Juventas Therapeutics Inc is categorized under Biotechnology Products and Services in Cleveland, OH .
Juventas Therapeutics Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Rahul Aras, Chief Executive Officer at the company’s single location by writing to 3615 Superior Avenue East, Cleveland, Ohio OH 44114 or by phoning (216) 273-4000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Juventas Therapeutics Inc |
| Contact Person: | Rahul Aras, Chief Executive Officer |
| Address: | 3615 Superior Avenue East, Cleveland, Ohio 44114 |
| Phone Number: | (216) 273-4000 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Juventas Therapeutics Inc was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Rahul Aras, Chief Executive Officer for inquiries that concern Juventas Therapeutics Inc by calling the company number (216) 273-4000, as your correspondence is most welcome. Additionally, the physical location of the single location of Juventas Therapeutics Inc can be found at the coordinates 41.512566,-81.665602 as well as the street address 3615 Superior Avenue East in Cleveland, Ohio 44114.
For its online presence, you may visit Juventas Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.